These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 26803692)

  • 1. nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.
    Parikh V; Kutlu MG; Gould TJ
    Schizophr Res; 2016 Mar; 171(1-3):1-15. PubMed ID: 26803692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.
    Fowler CD; Arends MA; Kenny PJ
    Behav Pharmacol; 2008 Sep; 19(5-6):461-84. PubMed ID: 18690103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.
    Wing VC; Wass CE; Soh DW; George TP
    Ann N Y Acad Sci; 2012 Feb; 1248():89-106. PubMed ID: 22129082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems.
    Mackowick KM; Barr MS; Wing VC; Rabin RA; Ouellet-Plamondon C; George TP
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():79-85. PubMed ID: 23871750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco addiction: a biochemical model of nicotine dependence.
    Ortells MO; Barrantes GE
    Med Hypotheses; 2010 May; 74(5):884-94. PubMed ID: 19962246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.
    Dalack GW; Healy DJ; Meador-Woodruff JH
    Am J Psychiatry; 1998 Nov; 155(11):1490-501. PubMed ID: 9812108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine effects in adolescence and adulthood on cognition and α₄β₂-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia.
    Berg SA; Sentir AM; Bell RL; Engleman EA; Chambers RA
    Psychopharmacology (Berl); 2015 May; 232(10):1681-92. PubMed ID: 25388292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on the Receptor-ligand Molecular Interactions in the Nicotinic Receptor Signaling Systems.
    Liu W; Su K
    Pak J Biol Sci; 2018; 21(2):51-66. PubMed ID: 30221881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions.
    Greenbaum L; Lerer B
    Mol Psychiatry; 2009 Oct; 14(10):912-45. PubMed ID: 19564872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine dependence and psychiatric disorders.
    Salín-Pascual RJ; Alcocer-Castillejos NV; Alejo-Galarza G
    Rev Invest Clin; 2003; 55(6):677-93. PubMed ID: 15011738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.
    Esterlis I; Ranganathan M; Bois F; Pittman B; Picciotto MR; Shearer L; Anticevic A; Carlson J; Niciu MJ; Cosgrove KP; D'Souza DC
    Biol Psychiatry; 2014 Sep; 76(6):495-502. PubMed ID: 24360979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine Addiction and Psychiatric Disorders.
    Kutlu MG; Parikh V; Gould TJ
    Int Rev Neurobiol; 2015; 124():171-208. PubMed ID: 26472530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.
    Ochoa EL; Lasalde-Dominicci J
    Cell Mol Neurobiol; 2007 Aug; 27(5):609-39. PubMed ID: 17554626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery.
    Papke RL; Dwoskin LP; Crooks PA
    J Neurochem; 2007 Apr; 101(1):160-7. PubMed ID: 17241116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between nicotine dependence and the endophenotype-related trait of cognitive function but not acoustic startle reponses in Japanese patients with schizophrenia.
    Kishi T; Fukuo Y; Okochi T; Kawashima K; Moriwaki M; Furukawa O; Musso GM; Fujita K; Correll CU; Iwata N
    Hum Psychopharmacol; 2013 May; 28(3):220-9. PubMed ID: 23553665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoking in Egyptian schizophrenia patients with and without obsessive-compulsive symptoms.
    Fawzi MH; Fawzi MM; Khedr HH; Fawzi MM
    Schizophr Res; 2007 Sep; 95(1-3):236-46. PubMed ID: 17662578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner.
    Pistillo F; Fasoli F; Moretti M; McClure-Begley T; Zoli M; Marks MJ; Gotti C
    Pharmacol Res; 2016 Jan; 103():167-76. PubMed ID: 26631628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking in Schizophrenia: an Updated Review.
    Šagud M; Vuksan-Ćusa B; Jakšić N; Mihaljević-Peleš A; Rojnić Kuzman M; Pivac N
    Psychiatr Danub; 2018 Jun; 30(Suppl 4):216-223. PubMed ID: 29864763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia praecox redux: a systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia.
    Rowe AR; Mercer L; Casetti V; Sendt KV; Giaroli G; Shergill SS; Tracy DK
    J Psychopharmacol; 2015 Feb; 29(2):197-211. PubMed ID: 25567553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.
    Boggs DL; Carlson J; Cortes-Briones J; Krystal JH; D'Souza DC
    Curr Pharm Des; 2014; 20(31):5077-92. PubMed ID: 24345265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.